Overview
Description
Organigram Holdings Inc. is a Canadian company focused on the cannabis industry, primarily engaged in producing and selling cannabis and cannabis-derived products. Its primary function is to cater to both the medical and adult-use cannabis markets, offering a diverse range of products including dried flower, pre-rolls, edibles, and vape oils. Organigram is known for its innovative approach to cultivation, leveraging advanced technologies and facilities to ensure high-quality and consistent product offerings.
The company impacts various sectors, notably pharmaceuticals, consumer goods, and wellness markets, as it capitalizes on the expanding legalization and increasing demand for cannabis products. As a significant player in the North American cannabis market, Organigram positions itself strategically with its multi-faceted brand portfolio, aiming to appeal to a broad demographic by addressing both medicinal and recreational needs.
Headquartered in Moncton, New Brunswick, Organigram Holdings Inc. has a substantial market role as it contributes to the evolving cannabis landscape, navigating regulatory challenges and participating in significant industry developments. Its efforts in research and product innovation underscore its influence and commitment to growth in the dynamic cannabis sector.
About
CEO
Ms. Beena G. Goldenberg
Employees
1093
Address
145 King Street West
Suite #1400
Toronto, M5H 1J8, ON
Canada
Suite #1400
Toronto, M5H 1J8, ON
Canada
Phone
844-644-4726
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Germany
MIC code
XSTU